AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
For the first time since 2019, the American Association for Cancer Research (AACR) Annual Meeting is set to return...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
Tuesday, March 8, marked International Women’s Day, a global celebration of the social, economic, cultural, and political achievements of...
This year, the American Association for Cancer Research (AACR) will celebrate its 115th birthday. From the very beginning, women...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...